Bio-Rad Laboratories | BIO - Debt


Bio-Rad Laboratories reported $1.41B in Debt for its fiscal quarter ending in June of 2025.





Debt Change Date
Abbott USD 12.94B 496M Sep/2025
Agilent USD 3.41B 640M Jun/2025
Becton, Dickinson and Co. USD 19.18B 160M Sep/2025
Bio Techne USD 260M 40M Dec/2025
Bio-Rad Laboratories USD 1.41B 204.6M Jun/2025
Bruker USD 2.44B 321.5M Jun/2025
Charles River Laboratories USD 2.79B 74.83M Jun/2025
Danaher USD 18.42B 1.56B Dec/2025
Exact Sciences USD 2.34B 15.24M Sep/2025
General Electric Aerospace USD 20.49B 344M Dec/2025
Hologic USD 2.63B 104.3M Sep/2025
Illumina USD 2.6B 137M Jun/2025
IQVIA Holdings USD 14.96B 533M Sep/2025
Laboratory Of America USD 6.55B 26.4M Jun/2025
Merck USD 41.37B 5.97B Sep/2025
Mettler Toledo International USD 2.18B 109.83M Jun/2025
Myriad Genetics USD 59.3M 19.7M Mar/2025
Quest Diagnostics USD 6.38B 525M Jun/2025
Repligen USD 533.72M 149.97M Jun/2025
Revvity USD 3.37B 5.86M Sep/2025
Roche Holding CHF 33.03B 1.41B Jun/2025
Siemens EUR 56.69B 834M Jun/2025
Standard Biotools USD 27.39M 1.23M Sep/2025
Thermo Fisher Scientific USD 35.68B 451M Sep/2025
Tosoh JPY 179.1B 25.51B Mar/2025
Waters USD 1.54B 36.51M Jun/2025